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Abstract Biofilm formation in urinary indwelling catheters is
one of the most critical issues that patients face. Catheters
were coated with poly(catechin)-antibiotic conjugates with
enhanced antimicrobial properties. Catechin was conjugated
with two antibiotics, namely trimethoprim (TMP) and sulfa-
methoxazole (SMZ) via activation with N,N′-disuccinimidyl
carbonate (DSC) and subsequent coupling to molecules con-
taining α-amine moieties. Silicone and polyurethane catheters
were functionalized in situ through laccase oxidation of
catechin-antibiotic conjugates. Four antimicrobial coatings
were produced, namely with poly(catechin), poly(catechin)-
TMP, poly(catechin)-SMZ and poly(catechin)-TMP-SMZ.
The bacterial adhesion reduction was tested on the function-
alized devices using gram-negative and gram-positive strains.
The most significant reduction in adhesion was observed with
poly(catechin)-TMP (gram-negative −85 % and gram-
positive −87 %) and with poly(catechin)-TMP-SMZ (gram-
negative −85 % and gram-positive −91 %). The cytotoxicity
to mammalian cells was tested by indirect contact for 5 days
and revealed that all the tested coatings supported more than
90 % of viable cells. A promising approach for the increase of
the indwelling catheter lifespan was developed aiming to
reduce catheter-associated chronic infections.
Keywords Laccase . Catechin . Trimethoprim .
Sulfamethoxazole . Antimicrobial . Catheters
Introduction
Lengthy hospital stays have been shown to be associated with
a higher risk of chronic infection (Eckmann et al. 2013). It is
thought that many of these infections result from bacteria
growing on the outer and/or inner surface of indwelling de-
vices leading to biofilm formation. The typical strategy to
eradicate bacteria is by the use of antibiotics (Hancock
2005). However, this approach has not been efficient enough
since bacteria are increasingly adopting resistance mecha-
nisms. Indeed, the initial attachment of planktonic bacteria
to a surface may be vulnerable to the antibiotic action, but the
additional binding and microcolonization of bacteria that pro-
motes the biofilm formation are associated with high tolerance
to them (Høiby et al. 2010; Shafahi and Vafai 2010; Smith
2005). This resistance may occur through antibiotic inactiva-
tion by modification of its chemical moiety, the specific mod-
ification of the macromolecular target and the prevention of
antibiotics from reaching their targets (cell membranes, cell-
wall biosynthesis enzymes and substrates, bacterial protein
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synthesis and bacterial nucleic acid replication/repair) by re-
ducing uptake or through antibiotic efflux (Alanis 2005;
Hancock 2005). In addition, once installed, the biofilms also
possess resistance mechanisms such as physical or chemical
diffusion barriers to antimicrobial penetration, slow growth of
the biofilm due to nutrient limitation and activation of the
general stress response and the occurrence of a biofilm-
specific phenotype (Mah and O’Toole 2001; Prasanna and
Doble 2008). Therefore, the need for a new antimicrobial
solution with a distinct action mode from that provided by
the existing antibiotics has been the focus of various studies
(Cushnie and Lamb 2005; Orhan et al. 2010). Different bac-
tericidal and bacteriostatic approaches have been studied
aiming to improve antibiotic therapy including physiochemi-
cal modification of the biomaterial surface (Klibanov 2007;
Kowalczuk et al. 2010; Tiller et al. 2001), impregnation of
antimicrobial agents into medical device polymers (Bayston
et al. 2009; Desai et al. 2010; Kohnen et al. 2003) and the use
of electric fields (Ahmad et al. 2012; Lee et al. 2005; Lichter
and Rubner 2009). Regardless of some clinical success, the
effectiveness of these mechanisms is limited and can diverge
depending on the bacterial strains. Therefore, the development
of antimicrobial alternatives is still an important issue to be
addressed by the scientific community (Rodrigues 2011).
Among the natural products, it is possible to find a signif-
icant number of antimicrobial agents with a broad spectrum, a
low toxicity and acceptable pharmacokinetics which can be
useful to functionalize surfaces and subsequently reduce the
bacteria growing on invasive devices (Cushnie et al. 2003;
Cushnie and Lamb 2005, 2011). Polyphenols, a class of
natural compounds with a broad range of pharmacological
properties, have been the focus of scientific research aiming to
overcome the drawbacks of current drugs and produce more
effective products (Cushnie et al. 2003; Ouattara et al. 2011).
These highly hydroxylated compounds have well described
powerful biological activities and can be classified according
to their structure as phenolic acid derivates, flavonoids and
tannins (Alberto et al. 2011; Karou et al. 2005). Concerning
their antibacterial mechanism of action, it has been reported
that polyphenols can interfere with nucleic acid synthesis
(topoisomerase inhibition) (Auzanneau et al. 2012; Lambert
et al. 2005), cytoplasmic membrane damage (perforation and/
or a reduction in membrane fluidity) (Ajuwon et al. 2013),
energy metabolism (NADH-cytochrome c reductase inhibi-
tion) (Moini et al. 1999) and cell wall/membrane synthesis
inhibition (Palacios et al. 2014) reducing the bacteria coloni-
zation (Cushnie and Lamb 2005, 2011). Moreover, the use of
polyphenols in combination with other antimicrobial agents
has also been cited as a successful practice to fight the drug
resistance problem (Lin et al. 2008; Rizzo et al. 2014). The
synergistic effect provided by both may potentiate the antibi-
otic efficacy at lower concentrations decreasing adverse reac-
tions (Daglia 2012; Jigisha et al. 2012). Oxidized polyphenols
also demonstrate their capacity to inhibit bacterial growth
since their polymer size can contribute to the microorganism
toxification (Karou et al. 2005). Enzyme-induced oxidation
and coupling of phenolic functional groups result in polymer
surfaces useful for material functionalization (Gonçalves et al.
2013). This process can be supported by the use of laccase (p-
diphenol:dioxygen oxidoreductase, EC 1.10.3.2), an oxidative
enzyme that catalyses the one-electron oxidation of reducing
substrates such as phenols and their derivatives or aromatic
amines. The ability of laccases to act over a wide range of
substrates makes these enzymes extremely useful biocatalysts
for distinct biotechnological applications (Mot and Silaghi-
Dumitrescu 2012; Sharma et al. 2007).
In a previous study, it was reported that the in situ
functionalization of catheters through laccase polymerization
of catechin (natural phenol) reduced bacterial adhesion onto
the polyurethane and silicone catheter surface (Gonçalves
et al. 2013). Herein, the strategy was to in situ enzymatically
oxidize catechin-antibiotic conjugates with laccase aiming the
bacterial adhesion reduction onto the functionalized catheters.
The main advantage of producing conjugates containing anti-
biotics coupled to poly(catechin) lies on the ability of cate-
chins, and its polymerized derivatives, to act on and disturb
the bacterial membranes. Thus, two antibiotics commonly
used to treat chronic infections, namely trimethoprim (TMP)
and sulfamethoxazole (SMZ), were selected. Both act to in-
hibit different enzymatic steps of the folic acid pathway,
leading to the cessation of thymidinemonophosphate bacterial
synthesis which is required for the DNA replication (Zander
et al. 2010). The bacterial adhesion reduction was studied
using gram-positive and gram-negative bacteria, and normal
human skin fibroblast cells were selected for the cell viability
evaluation of the newly developed antimicrobial systems.
Materials and methods
Materials
Sterile single-lumen polyurethane (PU) and double-lumen
silicone catheters (SI) were supplied from Pronefro
(Portugal) and Degania Medical (Israel), respectively.
Laccase (EC 1.10.3.2) from ascomycete Myceliophthora
thermophila (17 g protein/L, 560 U/mL at 50 °C),
Novozym® 51003, was obtained from Novozymes
(Denmark). Mouse fibroblast cells L929 were acquired from
ATCC and maintained according to the supplier’s recommen-
dations. Mueller-Hinton (MH) broth, Dulbecco’s modified
Eagle’s medium (DMEM), L-glutamine, sodium bicarbonate,
sodium pyruvate, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT), dimethyl sulphoxide, catechin
hydrate, trimethoprim (TMP), sulfamethoxazole (SMZ),
N,N′-disuccinimidyl carbonate (DSC), 4-(dimethylamino)-
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pyridine (DMAP), methanol, sodium acetate trihydrate, 2,2′-
azino-bis-(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS)
and bovine serum albumin (BSA) were purchased from
Sigma-Aldrich (Spain). Bradford solution was acquired from
Bio-Rad Laboratories GmbH (Germany). Fetal bovine serum
(FBS) was obtained from Lonza (Walkersville, Inc., MD,
USA). Glacial acetic acid was purchased from Panreac
(Spain), and synthetic urine was acquired from Synthetic
Urine e.K. (Germany). All of these chemicals were used as
supplied without any further purification.
Bacterial strains
Pseudomonas aeruginosa PAO1 was provided by Dr. Pedro
Santos from CBMA (University of Minho, Portugal).
Escherichia coli HB101, Proteus mirabil is 933,
Staphylococcus aureus ATCC 6538, Staphylococcus
epidermidis ATCC 35983 and Bacillus subtilis 48886 were
obtained from University of Minho (Braga, Portugal).
Methods
Protein concentration and enzymatic activity of laccase
The total protein concentration of laccase was determined
following the Bradford’s methodology in which BSA was
used as standard (Bradford 1976). The enzymatic activity of
laccase was evaluated through oxidation of ABTS at 50 °C in
0.1 M sodium acetate buffer with pH 5 (Childs and Bardsley
1975). One unit of laccase (U) was defined as 1 μmol of
ABTS oxidized per minute. The protein quantification and
enzymatic activity of laccase were measured using a Helios
Gamma UV-vis spectrophotometer (Thermo Scientific,
Waltham, MA, USA).
Conjugation of catechin with TMP or SMZ
A reaction model for the synthesis of catechin-antibiotic con-
jugates was developed based on a previous work (Diamanti
et al. 2008). Figure 1 shows the chemical structure of all the
components involved in the conjugation reaction. The conju-
gation was initiated by the activation of hydroxyl groups
which was performed by mixing solutions of 0.03 M lyoph-
ilized catechin with 0.1 M DSC and 0.1 M DMAP in anhy-
drous 1,4-dioxane. The reaction remained under a nitrogen
atmosphere for 24 h. Subsequently, the organic solvent was
evaporated at reduced pressure. The white solid obtained was
washed with chloroform and filtered in order to remove the
DSC and DMAP that did not react. For the catechin-antibiotic
conjugation, 1 eq. of TMP or SMZ was added to the activated
catechin dissolved in methanol. The process was carried out
overnight at room temperature with constant stirring. Finally,
the solvent was evaporated at reduced pressure, and the ob-
tained powder was identified by Fourier transform infrared
(FTIR) analysis as the catechin-antibiotic conjugate.
Characterization of the catechin-antibiotic conjugates
After the chemical synthesis of catechin-antibiotic conjugates,
the reaction products were characterized by FTIR spectrosco-
py. FTIR measurements were recorded using a PerkinElmer
1600 spectrometer, by averaging 16 individual scans over the
range 4,000 cm−1 to 450 cm−1. The samples were prepared in
potassium bromide (KBr) disks.
Catheter functionalization through in situ polymerization
of catechin and catechin-antibiotic conjugates by laccase
action
The coating followed an experimental procedure previ-
ously optimized for catechin polymerization and attach-
ment onto the PU and SI catheter surface (Gonçalves
et al. 2013). Firstly, an alkaline pre-treatment was car-
ried out wherein catheters of 1 cm each were incubated
with 2 g/L sodium hydroxide at room temperature for
30 min under orbital agitation. Samples were washed
with distilled water. Then, the in situ catheter
functionalization was carried out using different concen-
trations of monomer: (1) 10 mM catechin, (2) 10 mM
catechin-TMP, (3) 10 mM catechin-SMZ and (4) 5 mM
catechin-TMP plus 5 mM catechin-SMZ. Each com-
pound was previously dissolved in methanol (5 % v/v)
and diluted in 0.1 M sodium acetate buffer (pH 5). The
phenolic oxidation proceeded with 2 U/mL laccase at
50 °C under 70 rpm for 2 h under aired conditions.
Washing procedures were realized with distilled water in
order to remove the non-attached polymer.
Colorimetric measurements of the functionalized catheters
The colour change after catheter functionalization was moni-
tored by colour strength estimation (k/s) using a Datacolor
Fig. 1 (+)-Catechin hydrate,
trimethoprim (TMP) and
sulfamethoxazole (SMZ)
structures
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apparatus at standard illuminant D65 (LAV/Spec. Excl., d/8,
D65/108) with the Kubelka-Munk equation (Eq. 1):
k
s
¼ 1−Rð Þ
2
2R
ð1Þ
where k is the absorbance coefficient, s is the scattering
coefficient and R is the reflectance ratio. The setting up of a
narrow wavelength peak was due to the polymer polydisperse
size which contributes differently to the emission spectra.
Therefore, the data correspond to the sum of k/s values
achieved in the wavelength range of 400–700 nm.
Water uptake measurements
The surface characterization in terms of water uptake of
the functionalized catheters was studied by measuring the
water contact angle using a Dataphysics instrument
(Filderstadt, Germany) and the OCA20 software
(Germany). A dosing volume of water droplet was set as
3 μL using a Hamilton 500-μL syringe type. Conditions
for measurement were selected as ellipse fitting. The data
were determined by averaging values at three different
points of each catheter sample.
Leaching profile of the functionalized catheters
The modified catheters were incubated with 0.01 M
phosphate-buffered saline (PBS) solutions at pH 7.4 and syn-
thetic urine during 15 days, at 37 °C and 70 rpm of agitation.
The leaching profile was studied in terms of colour strength
(k/s). Samples were tested in triplicate.
Antimicrobial assays
Determination of MIC
The minimum inhibitory concentration (MIC) was defined as
the lowest concentration of antimicrobial agent that inhibited
the microorganism growth in a microdilution well. Broth
microdilution test (Wiegand et al. 2008) was used to deter-
mine the MIC value of each developed conjugate against
gram-positive (S. epidermidis, S. aureus and B. subtilis) and
gram-negative strains (E. coli, Proteus mirabilis and
Pseudomonas aeruginosa). Firstly, the inocula were prepared
in Mueller-Hinton (MH) broth and grown overnight at 37 °C
with orbital agitation. Further, each inoculum was diluted in
MH broth until an optical absorbance of 0.05 at 600 nm. An
optical absorbance of 0.01 at 600 nm was established only for
Pseudomonas aeruginosa due to the fast growth of these
bacteria. Seven different concentrations of each compound
were prepared in MH broth, and 50 μL of each solution was
distributed in 96-well plates. Posteriorly, 50 μL of each bac-
terial isolate was added to the corresponding well, and the
plates were incubated at 37 °C for 16 h. Samples were tested
in duplicates, and theMIC values were achieved bymeasuring
the optical absorbance at 600 nm in a microplate reader
(SpectraMax® Plus384).
Bacteria adhesion assay
The antimicrobial efficiency of the modified catheters was
assessed in vitro against the gram-positive and gram-
negative strains previously mentioned. The aim was to test
the effect of coating on bacterial adhesion without interference
of any exterior effect, like proteins from urine. The bacterial
attachment onto the catheter surface was determined by an
adhesion assay under static conditions (Darouiche et al. 2009;
Gonçalves et al. 2013). The inocula were prepared in MH
broth and grown overnight at 37 °C with orbital agitation.
Further, each inoculum was diluted in MH broth until an
optical absorbance of 0.05 at 600 nm. Only for
Pseudomonas aeruginosa was established an optical absor-
bance of 0.01 at 600 nm due to the fast growth of these
bacteria. Sterilized (ethylene oxide) catheter segments of
1 cm each were individually placed in 2 mL of inoculated
MH broth and incubated for 16 h at 37 °C. Afterwards, the
samples were washed three times with sterile PBS and trans-
ferred to an Eppendorf tube containing 1 mL of PBS.
Adherent cells were removed by sonication at 42 kHz, 70-W
output for 2 cycles of 30 s, followed by vortexing at 2,500 rpm
during 2 min. Bacterial suspensions were serially diluted in
PBS and then plated onto MH-agar dishes. Except for
Pseudomonas aeruginosa and B. subtilis which remained at
room temperature, all the plates were incubated at 37 °C for
24 h and the colonies were counted. Samples were tested in
duplicates, and two independent assays were accomplished
for each microorganism. Non-coated catheters were used as
control samples for further comparison with all the other
coated samples.
Evaluation of the planktonic bacteria growth
The effect of each functionalized catheter in the planktonic
bacteria growth was observed. The procedure followed the
guidelines mentioned in the bacteria adhesion assay section.
After the incubation of modified catheters with each selected
bacteria at 37 °C for 16 h, 100μL of each sample was plated in
96-well plates and the optical absorbance at 600 nm was
measured with the microplate reader. Samples were tested in
duplicates, and the inoculum without catheter was used as
control.
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Surface analysis—SEM
The bacteria adhesion onto the catheter surface was con-
firmed by scanning electron microscopy (SEM). Firstly,
the bacteria were fixed at room temperature for 2 h using
2.5 % glutaraldehyde solution prepared in 0.1 M
cacodylate buffer (pH 7.2). Then, each sample was
washed three times with distilled water and plunged into
nitrogen liquid before freeze-drying under vacuum condi-
tions (Baillie and Douglas 1999; Hawser et al. 1998;
Steinbrecht and Müller 1987). For SEM analysis, the
samples were coated with gold and scanned at different
points using an electron microscope model LEICA S360
with a backscattered and secondary electron detector, at
×2,000 and ×10,000 magnification. The catheters non-
inoculated with bacteria were also analysed aiming to
evidence the polymer attachment onto sample surface.
Cell viability assay—indirect contact
The cytotoxicity evaluation of human cells when exposed to
the novel antimicrobial catheters was accomplished in two
steps, namely Dulbecco’s modified Eagle’s medium (DMEM)
was pre-conditioned in contact with each sample and the
resulting leachables were frozen for posterior application to
fibroblast cells. In the first stage, the sterilized (ethylene oxide)
catheter pieces (1 cm each) were disposed in 24-well plates
and submerged in DMEM containing 4 mM L-glutamine,
4.5 g/L glucose, 1.5 g/L sodium bicarbonate, 1 % Pen &
Strep and 1 % sodium pyruvate. The incubation was carried
out at 37 °C for three different incubation times, namely 1, 3
and 5 days. Subsequently, each inoculated medium was col-
lected into Eppendorf tubes and frozen at −80 °C. Further, the
L929 cells were cultured at 37 °C in a humidified atmosphere
with 5 % CO2. The cells were previously seeded in 24-well
tissue culture plates at a density of 30,000 cells/well. Just prior
to adding the leachables to the cells, they were supplemented
with FBS (10 % v/v) and L-glutamine. Cell viability was
evaluated at 37 °C after 24, 48 and 72 h of incubation by the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) reduction assay as a measure of cellular meta-
bolic viability. Cells incubated with dimethyl sulphoxide
(DMSO, 15 %) were used as cell death controls, and cells
grown with regular culture medium were used as live cell
controls. Additionally, non-coated catheters were considered
the main control for further comparison with all the other
coated samples.
Cell viability—MTT assay
After each incubation, the MTT solution (5 mg/mL, 50 μL)
was added to each well, and after 2 h at 37 °C in a humidified
5 % CO2 atmosphere, the medium was replaced with DMSO/
ethanol solution (1:1 v/v, 500 μL). When the reaction product
(MTT formazan) was completely dissolved, 150 μL of each
solution was transferred in triplicate to a 96-well plate, and the
absorbance was read at 570 and 690 nm using a multiwell
plate reader spectrophotometer. The relative cell viability was
calculated considering the non-coated catheter incubated for
24 h as reference (100 % viability). Samples were tested in
duplicates, and four independent assays were performed for
each coating.
Statistical analysis
Data was statistically analysed through one-way ANOVA and
two-way ANOVA test, respectively. GraphPad Prism 5.0 for
Windows was the software used. Significant differences were
identified as P<0.05.
Results
Characterization of catechin-antibiotic conjugates
As previously described, the hydroxyl groups present on the
natural phenol structure were firstly activated by reacting with
DSC and DMAP. Then, each antibiotic was mixed with the
modified catechin, and the conjugation was accomplished
(Fig. 2). The chemical characterization of each reaction prod-
uct was carried out by FTIR. Figure 3 shows the FTIR spectra
achieved for catechin before and after coupling with the linker
(DSC) and with the selected antibiotics, TMP and SMZ. The
general spectrum ranging from 4,000 to 500 cm−1 correspond-
ing to each compound and an amplification of the most
noising part (from 2,000 to 400 cm−1) are presented. By this
way, it was possible to verify the spectral differences after
each stepping process and comprove the final product
achievement.
Catheter functionalization through in situ polymerization
of catechin and catechin-antibiotic conjugates by laccase
action
The attachment of catechin and catechin-antibiotic conjugates
onto the PU and SI catheters was assessed using laccase as
biocatalyst. The end products of enzymatic oxidation were
detected by UV-visible spectrophotometry. After laccase ad-
dition, the intensity of catechin peak at around 270 nm de-
creased comparatively to the catechin-antibiotic conjugates
peak. On the other hand, the poly(catechin) peak at 460 nm
was more pronounced than the peak of conjugate (data not
shown). Thus, the free form of catechin monomer proved to
be more easily oxidized by laccase than when it is conjugated
with antibiotics. The in situ functionalization of catheters
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followed the steps represented in Fig. 4. Catechin-antibiotic
conjugates were efficiently oxidized by laccase action and
attached onto the catheter surface. The colour strength mea-
surements allowed observing the differences between non-
functionalized and functionalized samples. Concerning these
results, PU coating was more effective than the SI coating
since highest k/s spectral values were observed (Fig. 5).
Besides, it was also noteworthy that poly(catechin) coating
retains highest colour strength intensity than the
poly(catechin)-antibiotics, confirming the previous mentioned
UV-visible results.
Water uptake of functionalized catheters
The PU and SI catheter hydrophobicity decreased after each
functionalization process as it was confirmed by the water
contact angle reduction relatively to the non-coated catheter.
The starting water contact angle of 114.55° and 134.35° for
PU and SI catheters, respectively, was reduced in 25° and 2°
after the poly(catechin) attachment onto the catheter surface.
On the other hand, the highest hydrophobicity decreasing was
attained with poly(catechin)-antibiotic conjugate coating
yielding less 45° and 8° of water contact angle than the non-
Fig. 2 Reaction scheme of catechin activation followed by its chemical conjugation with trimethoprim (TMP) or sulfamethoxazole (SMZ)
Fig. 3 FTIR spectra obtained for
catechin versus catechin-DSC (a),
catechin versus catechin-TMP (c,
d) and catechin versus catechin-
SMZ (e) using scales from 4,000
to 500 cm−1. b, d, f are
expansions of each spectrum
from 2,000 to 400 cm−1
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coated samples for PU and SI catheters, respectively (data not
shown). Therefore, the hydrophobicity reduction was more
pronounced on PU catheters than on SI devices. Comparing
both poly(catechin)- and poly(catechin)-antibiotic-coated
samples, a highest hydrophobicity decrease was observed on
the later ones.
Leaching profile of the functionalized catheters
In order to simulate the in vivo conditions for intravenous and
urinary applications, all the modified catheters were incubated
in PBS and in synthetic urine solutions at 37 °C for 15 days.
Figure 6 presents the colour strength measurements for each
coated sample before (0 days) and after 15 days of incubation.
The loss of polymer attached onto the PU and SI catheter
surface was evident for both PBS and synthetic urine solu-
tions. However, the colour strength decreasing was less pro-
nounced on PU devices. Nevertheless, more than a half of the
coloration remained in each coated catheter surface, revealing
that a high content of antimicrobial polyphenol remains on the
medical devices.
Antimicrobial activity of phenolic-antibiotic conjugates
Minimum inhibitory concentrations (MICs)
The development of novel catechin-antibiotic conjugates as
well as their enzymatic polymerization leads to structural
conformat ion changes of both TMP and SMZ.
Consequently, the antimicrobial profile of free antibiotics
was also modified, and for this reason, the MIC values of
each synthetized compound were determined (Table 1). In
general, the chemical catechin-antibiotic conjugation and the
enzymatic oxidation of each conjugate maintained or in-
creased the minimum concentration required to promote bac-
terial growth inhibition. Only when the SMZ was present in
the poly(catechin) conjugate structure, the MIC value for
E. coli and Proteus mirabilis was reduced. Unfortunately, it
was not possible to achieve any MIC values of antibiotic
conjugates for Pseudomonas aeruginosa neither of SMZ con-
jugates for S. aureus.
Bacterial adhesion onto the functionalized catheter surface
As previously mentioned, the strong adhesion on the outer
and/or inner surface of indwelling devices is the first stage of
the mechanism of biofilm formation (Prasanna and Doble
2008). For this reason, the bacterial adhesion test was per-
formed on each developed coating. Figure 7 shows the effect
of poly(catechin) and poly(catechin)-antibiotic conjugates as
antimicrobial coating of PU and SI catheters. Overall, the
antimicrobial efficiency was more evident for PU devices.
Both gram-positive and gram-negative bacteria adhesion to
Fig. 4 In situ laccase
functionalization of polyurethane
(PU) and silicone (SI) catheters
using catechin-TMP and/or
catechin-SMZ conjugates
(10 mM substrate; 2 U/mL
laccase; 0.1 M sodium acetate
buffer (pH 5) at 50 °C for 2 h)
Fig. 5 Colour strength (checksum k/s) of each modified polyurethane
and silicone catheters with poly(catechin) (PCAT), poly(catechin)-tri-
methoprim (PCAT-TMP), poly(catechin)-sulfamethoxazole (PCAT-
SMZ) or both poly(catechin)-antibiotic conjugates (PCAT-TMP-SMZ).
Enzymatic functionalization of catheters was carried out using 2 U/mL
laccase in 0.1 M methanol/sodium acetate buffer (pH 5) at 50 °C under
70 rpm for 2 h
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the catheter surface were affected by poly(catechin) or
poly(catechin)-antibiotic conjugate action. The analysis of
the four coatings developed revealed that the presence of
poly(catechin)-TMP-SMZ promoted the highest reduction of
bacterial adhesion. From all the microorganisms tested,
Pseudomonas aeruginosa was less affected by the catheter
surface modification, with only one logarithmic unit of adhe-
sion reduction observed in all the conditions tested.
Effect of the coated catheters in the planktonic culture growth
This study was carried out by incubation of PU-coated cath-
eters with the selected bacterial strains. PU material was
chosen for these tests, since it revealed the best coating levels
with lowest leaching properties. The inoculum of each coated
catheter with each bacterial strain studied revealed that, except
for Pseudomonas aeruginosa, all the novel antimicrobial
catheters inhibited the planktonic culture growth. The
poly(catechin) coating inhibited around 21–43 and 13–38 %
of planktonic bacteria growth for gram-negative and gram-
positive strains, respectively. On the other hand, the most
pronounced inhibition was verified with the poly(catechin)-
antibiotic conjugate coating. The planktonic culture growth
was reduced between 28–55 and 19–80 % for gram-negative
and gram-positive strains, respectively (Fig. S1).
Surface analysis—SEM
The bacteria adhesion reduction on functionalized catheter
surface was performed by SEM analysis after inoculation of
samples with a gram-negative (E. coli) and a gram-positive
(S. epidermidis) strains. Once again, the PU material was
selected for these tests, since it revealed the best coating
levels, lower leaching and the lowest number of bacteria
colony-forming units on the catheter surface. Figure 8 shows
the SEM images attained for each inoculated sample as well as
evidences of the polymer attachment onto the catheter surface
(non-inoculated samples). When the non-treated PU catheters
were exposed for 16 h to bacterial suspension, an extremely
higher colonization than the functionalized samples was evi-
dent for both bacteria. On the devices coated with
poly(catechin), a significant decrease of adherent cells was
Fig. 6 Colour strength (checksum k/s) of each modified polyurethane
and silicone catheters before (0 days) and after incubation with PBS and
synthetic urine at 37 °C for 15 days with slow agitation. Poly(catechin)
(PCAT), poly(catechin)-trimethoprim (PCAT-TMP), poly(catechin)-
sulfamethoxazole (PCAT-SMZ) or both poly(catechin)-antibiotic conju-
gates (PCAT-TMP-SMZ) were the developed coating. The
functionalization process proceeded using 2 U/mL laccase in 0.1 M
methanol/sodium acetate buffer (pH 5) at 50 °C under 70 rpm for 2 h
Table 1 Minimum inhibitory concentrations (mg/L) for each developed conjugate, namely catechin-trimethoprim (PCAT-TMP), poly(catechin)-
trimethoprim (PCAT-TMP), poly(catechin)-sulfamethoxazole (CAT-SMZ) and poly(catechin)trimethoprim-sulfamethoxazole (PCAT-TMP-SMZ)
E. coli P.mirabilis P.aeruginosa B. subtilis S.aureus S.epidermidis
TMP 0.1–0.2 2–4 – 0.25–0.5 1.5–3 0.5–1
CAT-TMP 0.2–0.4 2–4 – 0.5–1 3–6 0.5–1
PCAT-TMP 0.4–0.6 2–4 – 0.25–0.5 6–12 2–4
PCAT-TMP-SMZa 0.4–0.6 4–8 – 0.25–0.5 6–12 2–4
SMZ 4–8 4–8 – 0.06–0.12 – 1–2
CAT-SMZ 2–4 4–8 – 0.12–0.24 – 2–4
PCAT-SMZ 32–64 2–4 – 0.06–0.012 – 2–4
PCAT-TMP-SMZb 2–4 2–4 – 0.06–0.12 – 2 - 4
“–” non-effective inhibitory response
a Taking into account the MIC reference value of TMP
b Taking into account the MIC reference value of SMZ
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notorious. When polycatechin-antibiotic conjugates were ap-
plied, the bacteria attachment reduced significantly as well as
the number of bacterial colonies.
Coated catheter cytotoxicity towards cultured mammalian
cells
The final application for the coated PU and SI catheters, as
indwelling devices, demands strict control of their toxicity to
cells. Thus, it was important to assess cell viability of mam-
malian cell cultures exposed to the leachables. For this, bio-
material reference cell line L929 (mouse fibroblasts) was
cultured and exposed to solutions, in which the modified
catheters were previously conditioned. Non-coated catheters
were used as control samples. The effect of all the coating
process without phenolic compounds was also verified.
Figure 9 demonstrates the relative cell viability profile
achieved. Comparing both control and coated devices, it was
observed that significant differences on relative cell viability
were only observed after 5 days of incubation in DMEM and
48 h in contact with L929 cells. Nevertheless, viability values
around 90 % were maintained with all the antimicrobial
coatings developed. For both materials studied, the cellular
morphology was not compromised (data not shown).
Discussion
The synthesis of polymer-antibiotic conjugates for therapeutic
applications has been the target of various research studies
(Kopeček 2013; Pasut and Veronese 2007). In this study, a
strategy based on the enzymatic polymerization of monomer-
antibiotic conjugates was developed. The monomer selected
was catechin, a natural flavonoid which previously proved to
be easily polymerized by laccase oxidation showing
Fig. 7 Bacteria colony-forming
units (CFUs) adhered on
functionalized catheter surface for
gram-negative (E. coli,
P. aeruginosa and P. mirabilis)
and gram-positive strains
(B. subtilis, S. aureus and
S. epidermidis). Four coatings
were analysed: poly(catechin)
(PCAT), poly(catechin)-
trimethoprim (PCAT-TMP),
poly(catechin)-sulfamethoxazole
(PCAT-SMZ) and poly(catechin)-
trimethoprim-sulfamethoxazole
(PCAT-TMP-SMZ). Statistically
significant differences were
achieved by comparing of each
coating with non-coated samples
(CONTROL). ***Amount of
adhered cells on coated catheter is
significantly different than non-
coated sample (P<0.001);
**amount of adhered cells on
coated catheter is significantly
different than non-coated sample
(P<0.01); *amount of adhered
cells on coated catheter is
significantly different than non-
coated sample (P<0.05)
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antimicrobial efficiency when used as catheter coating
(Gonçalves et al. 2013). The antibiotics chosen were TMP
and SMZ usually recommended by clinical guidelines for
empirical treatment of chronic infections and used as com-
mercial antibiotic in the market named as Bactrim® (Jancel
and Dudas 2002; Miller and Tang 2004). In catechin-
antibiotic conjugation, the phenolic compound affinity to the
antibiotics was prompted through hydroxyl group activation
(Aldwin et al. 1990). The reaction yield was improved by
using DMAP which deprotonated the hydroxyl group making
it more reactive towards DSC. Then, the activated hydroxyl
group reacted with the electrophilic carbonyl of DSC leading
to the activated succinimidyl group. Posteriorly, the activated
catechin was coupled with amino groups present on the TMP
and SMZ structure immersing the modified monomer into
antibiotic solution (Diamanti et al. 2008). The final products,
namely catechin-DSC, catechin-TMP and catechin-SMZ,
were characterized by FTIR analysis. On catechin spectrum,
Fig. 8 Scanning electron
microscopy (SEM) analysis of
each modified polyurethane
catheter after inoculum with
E. coli and S. epidermidis at 37 °C
for 16 h. Poly(catechin) (PCAT),
poly(catechin)-trimethoprim
(PCAT-TMP), poly(catechin)-
ulfamethoxazole (PCAT-SMZ),
poly(catechin)-trimethoprim-
sulfamethoxazole (PCAT-TMP-
SMZ) and the non-coated sample
(CONTROL) were observed. The
images were recorded with a
magnitude of ×2,000 and ×10,000
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the characteristic absorption regions of hydroxyl group O-H
(3,508–3,270 cm−1), aromatic rings by C=C group
(1,634 cm−1) and also C-O group around 1,149–1,033 cm−1
are evidenced (Maoela et al. 2009).When the hydroxyl groups
of catechin were activated by reacting with DSC, the intensity
of hydroxyl group O-H band decreased, and a prominent triple
peak appeared around 1,570 cm−1 proving the formation of a
succinimidyl ester. Concomitantly, a stretching vibration of
aromatic nitro N-O groups occurred at 1,290 cm−1. Also a new
peak came up around 1,770 cm−1 corresponding to the car-
bonyl C=O groups evident on DSC structure as well as on the
ester linkage (Baca et al. 2009; Jo et al. 2000; Sam et al. 2011).
Afterwards, the coupling reaction of activated catechin with
antibiotics was assessed, and consequently, some new peaks
were observed such as the N-H bending vibration of primary
amines around 1,650 cm−1 and the C-N stretching vibration of
aliphatic amines in the region 1,140–1,080 cm−1, both char-
acteristic of the TMP structure. Moreover, the presence of
methoxy (O-CH3) group was identified by a small stretch
peak at 2,940 cm−1 as well as by the methyl (C-H) vibrations
at 1,460 cm−1 (Coates 2000; Stuart 2004; Zade et al. 2011).
Around 1,560–1,510 cm−1, it was possible to observe the non-
symmetrical substitutional aromatic ring present on TMPwith
N as a substitutional atom (Franklin et al. 2009; Ungurean
et al. 2013). As a result of catechin-SMZ coupling, the pres-
ence of imino C=N groups which exhibit absorption at
1,595 cm−1, the stretching in the sulphate S=O bond around
1,260–1,160 cm−1 characteristic from the SMZ compound,
and the equivalent to thiol C-S and C-S-H stretching vibra-
tions between 720 and 550 cm−1 was confirmed. In addition,
the amines N-H bending around 1,650 cm−1 and the C-N
stretching vibration at 1,150–1,090 cm−1 was also evident.
The nitro N-O stretching bands occurred around 1,565–
1,465 cm−1 as well as around 1,320–1,240 cm−1 accordingly
to the corresponding symmetry (Coates 2000; Silva et al.
2009).
Once the successful development of catechin-antibiotic
conjugates was confirmed, the in situ laccase oxidation of
the phenolic monomer part was assessed for PU and SI
catheter functionalization. As it was reported (Gonçalves
et al. 2013; Guimarães et al. 2011; Jeon et al. 2012; Silva
et al. 2011), the phenols can be directly oxidized by laccase
yielding the corresponding phenoxy free radicals that become
quinone intermediates. These compounds can react among
each other through either coupling-based polymerization or
radical rearrangement giving the dead-end products. On this
work, the polymerization yield was monitored by UV-visible
spectrophotometry wherein the band intensity of each com-
pound is directly proportional to concentration values. Both
unmodified and conjugated catechins were efficiently oxi-
dized, however, in a different polymerization degree. The
non-modified monomer was more easily converted into the
Fig. 9 Relative L929 cell
viability after 24, 48 and 72 h of
culture with DMEM solutions
pre-inoculated with
functionalized polyurethane (a–c)
and silicone (d–f) catheters for 1,
3 and 5 days. Non-coated sample
was used as CONTROL.
Poly(catechin) (PCAT),
poly(catechin)-trimethoprim
(PCAT-TMP), poly(catechin)-
sulfamethoxazole (PCAT-SMZ)
and poly(catechin)-trimethoprim-
sulfamethoxazole (PCAT-TMP-
SMZ) were the coated samples.
Data were achieved in relation to
the control for one incubation day
and show the mean values of
three replicates from four
experiments carried out
independently. Statistical
significant differences are
indicated. ***Significantly
different from the control
(P<0.001); **significantly
different from the control
(P<0.01); *significantly different
from control (P<0.05)
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corresponding polymer than the conjugate compounds (data
not shown). This behaviour may be due to the modified
catechin possessing less hydroxyl groups available for the
oxidative coupling reactions (Guimarães et al. 2011; Silva
et al. 2011). The poly(catechin) or poly(catechin)-antibiotic
conjugate attachment onto the catheter surface can be mostly
attributed to the reaction of the intermediate quinones with
highly reactive hydroxyl −OH and amine −NH groups
resulting from the alkaline pre-treatment of SI and PU cathe-
ters, respectively (Chattopadhyay and Raju 2007; Gonçalves
et al. 2013; Gopalakrishnana and Sujathaa 2011). However,
the catheter coating by means of adsorption mechanisms must
also be considered. The coloration observed after coating
results from the nature of the phenol that changed from
colourless (SI) or white (PU) to dark yellow when oxidized.
The colour strength measurements performed allowed the
effectiveness comparison of each coating since this parameter
is directly related with the amount of polymer covering the
catheter surface. PU devices were more efficiently coated with
poly(catechin) and poly(catechin)-antibiotic conjugates than
the SI catheters. Indeed, the previous alkaline hydrolysis of
PU catheters yielded hydrophilic carboxylic −COOH and
amine −NH groups available for reaction with quinone.
On the other hand, only one type of hydrophilic group
(−OH) was attained and available after SI sample hydro-
lysis. This would decrease the attachment yield of poly-
merized phenolic compounds onto the catheter surface.
Comparing both, polycatechin and poly(catechin)-antibiotic
conjugate, it is clear that the higher coverage of the
catheter surface was achieved with poly(catechin). The
lower number of hydroxyl groups available on the conju-
gates for enzymatic polymerization and the subsequent
attachment could reduce the final amount of polymer
obtained onto the catheter surface.
The coatings developed onto the catheter devices promoted
chemical and physical modifications at the surface level which
are essential to study. The water uptake is one of the key
parameters that could influence the bacterial adherence and
its proliferation onto the catheter surface. It is known that
hydrophobic organisms have preference for hydrophobic sur-
faces. When specific functional groups are applied as a coat-
ing, the hydrophobicity and surface charge can be modified
reducing the microorganism attachment, generating a more
biocompatible material (Prasanna and Doble 2008). Herein,
the poly(catechin) and poly(catechin)-antibiotic conjugates
coating reduced the hydrophobic character of both PU and
SI catheters. The highest hydrophobicity reduction was
attained on PU catheters coated with poly(catechin)-antibiotic
conjugates. This can be explained by the highest amount of
poly(phenol) attached onto the PU catheter surface as previ-
ously mentioned. Poly(catechin) possesses hydroxyl groups
on its structure conferring hydrophilic character to the material
surface. The presence of amine groups on both antibiotic
structures also contributes to decrease the hydrophobic nature
of catheters justifying the results obtained for poly(catechin)-
antibiotic conjugates.
The highest coating life-time was observed on the PU
catheters. The high amount of groups (carboxylic −COOH
and amine −NH) at their surface, available to react with
the poly(phenols), increases coating strength and thus con-
tributes to the life-time of the antimicrobial device.
Nevertheless, more than half of poly(catechin) or
poly(catechin)-antibiotic conjugates amount remained on
both PU and SI catheter surface. Therefore, the function-
alized catheters address to the need of invasive catheters
for longer periods.
The synthesis and characterization of the developed coat-
ings were followed by the conjugation process effect in the
MIC values of free antibiotics. As it was expected, once
combined to other molecules of those antibiotics, MIC values
changed. Indeed, the coupling reaction between catechin and
TMP or SMZ occurred through the nitrogen of the amine
groups reducing the tertiary amine moiety. Therefore, the
antimicrobial activity of the compounds was directly compro-
mised by the conjugation processes (Radjenović et al. 2009).
Although the produced catechin and poly(catechin)-antibiotic
conjugates still reduced bacterial growth, two antimicrobial
agents were successfully combined resulting in a novel model
to prevent bacterial infections. Moreover, both poly(catechin)
and poly(catechin)-antibiotic conjugate coatings gave a reduc-
tion in the bacterial adhesion as well as in the planktonic
culture growth for each microorganism studied. It is known
that flavonoids do not kill bacterial cells but merely induce the
formation of bacterial aggregates and thereby reduce the col-
ony number in viable counts (bacteriostatic activity) (Cushnie
and Lamb 2005). Catechins are a group of flavonoids that
have been demonstrating activity against gram-positive and
gram-negative bacteria damaging them by two possible mech-
anisms: firstly, catechins may perturb the lipid bilayers by
directly penetrating the membrane and disrupting the barrier
function; alternatively, these phenolic compounds may cause
membrane fusion which consists in a process that results in
intramembranous material leakage and consequent aggrega-
tion (Cushnie and Lamb 2005; Ikigai et al. 1993). Herein, the
reduction of bacterial adhesion was more pronounced using
poly(catechin)-antibiotic conjugates. Although lower coating
levels were achieved with conjugates, the amount attached
onto the catheter surface was sufficient to reduce the bacteria
adhesion. Comparing with non-treated catheters, SEM analy-
sis shows the bacteria colony reduction for each developed
coating. It is our assumption that, depending on the strength of
antibiotic-polymer interaction, the release of TMP or SMZ
could arise promoting its diffusion into the culture medium. In
addition, enzymes secreted by bacteria could also support the
drugs release (Kostakioti et al. 2005; Lee and Schneewind
2001;Wandersman 1992). The combination of two antibiotics
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in the same conjugate revealed to improve the antibacterial
efficacy of the coating preventing the microbial resistance
appearance (Monzón et al. 2001; Worthington and Melander
2013). A synergistic effect can be reached when the action
mechanisms of each compound, bactericidal or bacteriostatic,
are well defined (Hancock 2005). TMP and SMZ are bacteri-
ostatic antibiotics which inhibit enzymatic steps on the bacte-
rial folate biosynthesis and together allow a broad bacterial
spectrum of action. Indeed, SMZ inhibits dihydropteroate
synthetase (DHPS) responsible for the production of
dihydrofolate from p-aminobenzoic acid. Subsequently,
TMP inhibits dihydrofolate reductase (DHFR) which cataly-
ses the formation of tetrahydrofolate from dihydrofolate
(Eliopoulos and Huovinen 2001; Fresta et al. 1996; Vickers
et al. 2009). The main advantage to produce conjugates con-
taining antibiotic coupled to poly(catechin) lies on the ability
of catechins and its polymerized derivatives, to act on and
disturb the bacterial membranes. This property would poten-
tiate the antibiotic diffusion into cell interior causing a strong
bacterial reduction on the catheter surface (Fresta et al. 1996).
Aiming future medical applications, the viability of mamma-
lian cells exposed to leachables of the developed antimicrobial
coatings was evaluated. Even with some punctual interference
on cellular metabolism observed, the rule was that L929 cells
maintained more than 90 % viability even in longer incuba-
tions which is a very good indicator of the cytocompatibility
of the devices. This behaviour was similar for both PU and SI
catheters.
From this work resulted four novel antimicrobial coatings
for medical devices. Taking the advantage of poly(catechin)
and antibiotics properties, antimicrobial conjugates were de-
signed, and the obtained synergism allowed the inhibition of
planktonic bacteria growth and the bacterial adhesion reduc-
tion onto the coated surfaces. This synergism was more evi-
dent on poly(catechin)-TMP and poly(catechin)-TMP-SMZ
where a higher bacteria reduction was observed. Moreover,
the cellular metabolism assays demonstrate that the antimi-
crobial coatings developed are not harmful for the cellular
metabolism, maintaining more than 90% of cell viability after
the highest incubation time tested. A promising approach for
extending the life-span of indwelling catheters was developed.
Concomitantly, the catheter-associated infections could be
reduced and even improving the life quality of catheterized
patients.
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